Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kidney Cancer Research Bureau

Clinical trials sponsored by Kidney Cancer Research Bureau, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New antibody targets FGFR1 to fight metastatic cancers Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

New antibody targets FGFR1 to fight metastatic cancers

Disease control Recruiting now

This study tests a new drug called OM-RCA-01, an antibody that blocks a protein called FGFR1 found on some cancer cells. About 58 adults with metastatic kidney, lung, prostate, breast, or head and neck cancers that express FGFR1 will receive the drug by IV every two weeks. The go…

Phase 1/2 • Sponsor: Kidney Cancer Research Bureau • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC